BTMD
biote Corp

219
Mkt Cap
$102.17M
Volume
81,413.00
52W High
$6.98
52W Low
$2.71
PE Ratio
3.40
BTMD Fundamentals
Price
$3.25
Prev Close
$3.07
Open
$3.12
50D MA
$3.12
Beta
1.10
Avg. Volume
134,869.76
EPS (Annual)
$0.0921
P/B
-1.14
Rev/Employee
$908,714.29
Loading...
Loading...
News
all
press releases
Capricor (CAPR) Surges 5.3%: Is This an Indication of Further Gains?
Capricor (CAPR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·26d ago
News Placeholder
More News
News Placeholder
biote Corp. (BTMD) Tops Q2 Earnings Estimates
biote Corp. (BTMD) delivered earnings and revenue surprises of +66.67% and -1.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Tilray Brands, Inc. (TLRY) Q4 Earnings Beat Estimates
Tilray Brands (TLRY) delivered earnings and revenue surprises of +166.67% and -6.46%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Is biote Corp. (BTMD) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·4mo ago
News Placeholder
Biote Announces CEO Retirement and Succession Plan
biote Corp. (NASDAQ: BTMD) (Biote or the Company), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today...
Business Wire·9mo ago
News Placeholder
AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion
AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion PR Newswire...
PR Newswire·11mo ago
News Placeholder
Biote Reports Third Quarter 2024 Financial Results
Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for...
Business Wire·11mo ago
News Placeholder
Biote Reports Second Quarter 2024 Financial Results
Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for...
Business Wire·1y ago
News Placeholder
Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call
biote Corp. (Nasdaq: BTMD) (Biote or the Company), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today...
Business Wire·1y ago
News Placeholder
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares
biote Corp. (NASDAQ: BTMD) (Biote or the Company), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today...
Business Wire·1y ago

Latest BTMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.